The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity.

Proteins secreted from adipose tissue are increasingly recognized to play an important role in the regulation of glucose metabolism. However, much less is known about their effect on lipid metabolism. The fasting-induced adipose factor (FIAF/angiopoietin-like protein 4/peroxisome proliferator-activated receptor gamma angiopoietin-related protein) was previously identified as a target of hypolipidemic fibrate drugs and insulin-sensitizing thiazolidinediones. Using transgenic mice that mildly overexpress FIAF in peripheral tissues we show that FIAF is an extremely powerful regulator of lipid metabolism and adiposity. FIAF overexpression caused a 50% reduction in adipose tissue weight, partly by stimulating fatty acid oxidation and uncoupling in fat. In addition, FIAF overexpression increased plasma levels of triglycerides, free fatty acids, glycerol, total cholesterol, and high density lipoprotein (HDL)-cholesterol. Functional tests indicated that FIAF overexpression severely impaired plasma triglyceride clearance but had no effect on very low density lipoprotein production. The effects of FIAF overexpression were amplified by a high fat diet, resulting in markedly elevated plasma and liver triglycerides, plasma free fatty acids, and plasma glycerol levels, and impaired glucose tolerance in FIAF transgenic mice fed a high fat diet. Remarkably, in mice the full-length form of FIAF was physically associated with HDL, whereas truncated FIAF was associated with low density lipoprotein. In human both full-length and truncated FIAF were associated with HDL. The composite data suggest that via physical association with plasma lipoproteins, FIAF acts as a powerful signal from fat and other tissues to prevent fat storage and stimulate fat mobilization. Our data indicate that disturbances in FIAF signaling might be involved in dyslipidemia.

Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients.

The effect of aging on steady-state plasma concentrations of citalopram (CIT) and desmethylcitalopram (DCIT) was investigated in 128 depressive patients treated with 10-80 mg/day CIT. They were separated into three groups, with age up to 64 years (mean age+/-S.D.: 47+/-12 years; n=48), between 65 and 79 years (72+/-1 years; n=57), and from 80 years or older (84+/-1 years; n=23). Body mass index (BMI), renal and hepatic functions were similar in the three groups. A large interindividual variability of plasma levels of CIT (16-fold) and DCIT (12-fold) was measured for a given dose. The mean plasma levels of CIT corrected for a 20 mg daily dose were 55% higher in the very elderly (>=80 years) patients (65+/-30 ng/ml; p<0.001) and 38% higher in the elderly (65-79 years) patients (58+/-24 ng/ml; p<0.001) when compared to the adult patients (42+/-17 ng/ml). DCIT mean plasma level was 38% higher (p<0.05) in the group of very elderly patients (22+/-10 ng/ml) when compared to the adult patients (16+/-9 ng/ml). As a consequence, the mean plasma concentration of CIT+DCIT was 48% higher in the very elderly patients (86+/-36 ng/ml; p<0.001) and 33% higher in the elderly patients (77+/-28 ng/ml; p<0.001) when compared to the adult patients (58+/-21 ng/ml). Age correlated significantly with CIT (r=0.43, p<0.001), DCIT (r=0.28, p<0.01), and CIT+DCIT plasma levels (r=0.44, p<0.001), and thus accounts for 18% of the variability of CIT plasma levels, with no influence of gender. The recommended dose reduction of CIT in elderly patients seems therefore justified.

Radiolarian biochronology and Pacific origin of Jurassic-Cretaceous oceanic terranes in Costa Rica and Puerto Rico

AbstractAs demonstrated during several recent geological conferences, there is still a large debate concerning the origins of the Mesozoic oceanic remnants on the Caribbean Plate. The geodynamic models describing the Mesozoic history of the Caribbean realm can be divided into two main categories based on the origin of the Caribbean Plate: 1) An in situ origin between the Americas; 2) A Pacific origin and an eastward transport relative to the Americas. The study of the ribbon-bedded radiolarite is a key in determining the origins of associated Mesozoic oceanic terranes and may help to achieve a general agreement regarding the basic principles on the evolution of the Caribbean Plate. The Early Jurassic to early Late Cretaceous Bermeja Complex of Puerto Rico, witch contains serpentinized peridotite, altered basalt, amphibolite, and chert (Mariquita Chert Formation), and the contemporaneous Santa Rosa Accretionary Complex, which crops out in several half-windows along the south shores of the Santa Elena Peninsula in northwestern Costa Rica, are two of these little-known and crucial ophiolitic mélanges. The Manzanillo and Matambú fore-arc Terranes of the Nicoya Peninsula in the northwestern Costa Rica, which contain Late Cretaceous to Early Paleogene radiolarian-bearing siliceous mudstones and cherts associated with arc-derived mafic to intermediate volcaniclastics, bring important information on the history of the western active margin of the Caribbean Plate. A systematic radiolarian study of these three regions is presented herein in three different articles.The radiolarian biochronology of the Mariquita Chert Formation of the Bermeja Complex presented in this work indicate an early Middle Jurassic to early Late Cretaceous (late Bajocian-early Callovian to middle Albian-middle Cenomanian) age for the Mariquita Chert Formation. The illustrated assemblages contain 150 species, of which 3 are new (Pantanellium karinae, Loopus bermejaense, and L. boricus), and belonging to 59 genera. A review of the previous radiolarian published works on this formation and the results of this study suggest that the Bermeja Complex ranges in age from Middle Jurassic to early Late Cretaceous (late Aalenian to middle Cenomanian) and also reveal a possible feature of the complex, which is the youngling of radiolarian cherts from north to south, evoking a polarity of accretion. On the basis of a currently exhaustive inventory of the ribbonbedded radiolaritic facies on the Caribbean Plate, a re-examination of the distribution of Middle Jurassic sediments associated with oceanic crust from the Caribbean realm, and a paleoceanographical argumentation on the water currents, we come to the conclusion that the radiolarite and associated Mesozoic oceanic terranes of the Caribbean Plate are of Pacific origin. The previous argument for a Pacific origin of the Bermeja Complex presented by Montgomery et al. (1994a), based on their radiolarian age and their estimation of the oldest Proto-Caribbean oceanic crust, is nowadays seriously questionable, owing to the recent progresses in radiolarian biostratigraphy and new discoveries on the age of the first oceanic crust spreading between the Americas. Furthermore, we interpret the radiolarian Parvicingulidae-rich assemblages in the low-latitude Caribbean context as potential indicators of upwelling or land nutrients inputs, instead of indicators of paleolatitudes,as firstly stated by Pessagno and Blome (1986). Eventually, a discussion on the origin of the cherts of the Mariquita Formation illustrated by Middle Jurassic to middle Cretaceous geodynamic models of the Pacific and Caribbean realms bring up the possibility that the rocks of the Bermeja Complex are remnants of two different oceans.The Santa Rosa Accretionary Complex contains various oceanic assemblages of alkaline basalt, radiolarite and polymictic breccias. The radiolarian biochronology (19 illustrated assemblages, 232 species belonging to 63 genera) presented in this work indicate an Early Jurassic to early Late Cretaceous (early Pliensbachian to earliest Turonian) age for the sediments associated with oceanic basalts or recovered from blocks in breccias or megabreccias from the Santa Rosa Accretionary Complex. This study brings to light the Early Jurassic age of a sequence of ribbon-bedded radiolarite, which was previously thought to be of Cretaceous age, intruded by alkaline basalts sills. The presence of Early Jurassic large reworked blocks of radiolarite in a polymictic megabreccia, firstly reported by De Wever et al. (1985) is confirmed. Therefore, the alkaline basalt associated with these radiolarites could be of Jurassic age. In the Carrizal tectonic window, Middle Jurassic radiolarian chert blocks and Early Cretaceous brick-red ribbon-bedded radiolarites overlying pillow basalts are interpreted as fragments of a Middle Jurassic oceanic basement accreted to an Early Cretaceous oceanic plate, in an intra-oceanic subduction context. Whereas, knobby radiolarites and black shale at Playa Carrizal are indicative of a shallower middle Cretaceous paleoenvironment. Other younger oceanic remnants documented the rapid approach of the site of sedimentation to a subduction trench during the late Early Cretaceous (AlbianCenomanian), maybe early Late Cretaceous (Turonian).In total, 60 species belonging to 34 genera were present in relatively well-preserved radiolarian faunas from volcaniclastics and associated pelagic and hemipelagic rocks of the Matambú and Manzanillo terranes, ranging in age from Late Cretaceous to Early Paleogene (middle Turonian-Santonian to late Thanetian-Ypresian). This study shows that radiolarians can provide significant biostratigraphic control in the Nicoya Peninsula where very similar lithologies of different ages are present. Two radiolarian samples directly date the Berrugate Formation for the first time (middle Turonian-Santonian and Coniacian-Santonian). These ages allow to determine a volcanic arc activity on the western edge of the future Caribbean Plate at least since the Santonian that could have lasted through the middle Turonian-early Campanian interval by stratigraphic superposition. Moreover on the basis of these radiolarian ages, the Loma Chumico Formation of Albian age, and the Berrugate Formation of middle Turonian-early Maastrichtian age, can now be clearly differentiated. Two samples from the Sabana Grande Formation give a Coniacian-Santonian age and a Coniacian-Campanian age and indicate that there is a stratigraphic gap of ~10 million years between this formation and the underlying Albian Loma Chumico Formation.RésuméComme cela a pu se vérifier à plusieurs reprises lors de conférences géologiques récentes, le débat sur l'origine des terrains océaniques mésozoïques de la Plaque Caraïbes est toujours d'actualité. Les modèles géodynamiques décrivant l'histoire de la région caraïbes peuvent être classés en deux catégories basées sur l'origine de la Plaque Caraïbes : 1) Une origine in situ entre les Amériques ; 2) Une origine Pacifique et un transport vers l'est, par rapport aux Amériques. L'étude des radiolarites rubanées est capitale pour la détermination de l'origine des terrains océaniques allochtones du Mésozoïque et peut être utile pour parvenir à un compromis général concernant les principes basiques de l'évolution de la Plaque Caraïbes. Le complexe de Bermeja à Porto Rico qui est constitué de péridotites serpentinisées, de basaltes altérés, d'amphibolites et de cherts (Formation des Cherts de Mariquita), et le Complexe d'Accrétion de Santa Rosa qui affleure dans plusieurs demi-fenêtres tectoniques au sud de la Péninsule de Santa Elena au nord-ouest du Costa Rica sont deux de ces mélanges ophiolitiques peu décrits et déterminants. Les terrains de fore-arc de Manzanillo et de Matambu dans la Péninsule de Nicoya au nord-ouest du Costa Rica qui sont composés de calcaires siliceux et de cherts riches en radiolaires associés à du matériel volcanique d'arc mafique à intermédiaire, apportent d'importantes informations sur l'histoire de la marge active occidentale de la Plaque Caraïbe. Une étude systématique des radiolaires de ces trois régions est présentée dans ce travail sous forme de trois articles.La biochronologie des radiolaires de la Formation des Cherts de Mariquita du Complexe d'Accrétion de Santa Rosa présentée dans ce travail indique un âge Jurassique Moyen inférieur à Crétacé Supérieur inférieur (Bajocien supérieur-Callovien inférieur à Albien moyen-Cénomanien moyen) pour la Formation des Cherts de Mariquita. Les assemblages illustrés contiennent 150 espèces, parmis lesquelles 3 sont nouvelles (Pantanellium karinae, Loopus bermejaense et L. boricus), et appartenant à 59 genres différents. Une révision des travaux publiés précédemment sur les radiolaires de cette formation, ainsi que les résultats de cette étude suggèrent que le Complexe de Bermeja a un âge allant du Jurassique moyen au Crétacé Supérieur inférieur (Aalénien supérieur à Cénomanien moyen) et révèle aussi une caractéristique éventuelle du complexe qui est le rajeunissement des radiolarites du nord au sud, évoquant une polarité d'accrétion. Sur la base d'un inventaire actuellement exhaustif du facies radiolaritique rubané sur la Plaque Caraïbes, d'un nouvel examen de la distribution globale des sédiments du Jurassique Moyen associés à de la croûte océanique et d'une argumentation paléocéanographique sur les courants, nous arrivons à la conclusion que les radiolarites et les unités tectoniques océaniques du Mésozoïque associées de la Plaque Caraïbes sont d'origine pacifique. L'argument antérieur pour une origine pacifique du Complexe de Bermeja présenté par Montgomery et al. (1994a), basé sur leur âge à radiolaire et leur estimation de l'âge de la plus vieille croûte océanique des Proto-Caraïbes, est sérieusement remis en question aujourd'hui, en raison des progrès récents de la biostratigraphie des radiolaires et des nouvelles découvertes concernant l'âge du début de l'océanisation entre les Amériques. En outre, dans le contexte de basses latitudes des Caraïbes, nous interprétons les assemblages à radiolaires riches en Parvicingulidae comme étant des indicateurs potentiels d'apports en nutriments des zones d'uppwelling ou des terres, plutôt que des indicateurs de paléolatitudes, comme exposer pour la première fois par Pessagno et Blome (1986). Finalement, une discussion sur l'origine des cherts de la Formation de Mariquita illustrée par des modèles géodynamiques du Jurassique Moyen au Crétacé moyen des régions pacifique et caraïbes, fait poindre la possibilité que les roches du Complexe de Bermeja proviennent de deux océans différents.Le Complexe d'Accrétion de Santa Rosa contient plusieurs assemblages océaniques différents de basaltes alcalins, radiolarites et brèches polymictes. La biochronologie des radiolaires (19 assemblages illustrés, 232 espèces appartenant à 63 genres) présentée dans ce second travail indique un âge Jurassique Inférieur à Crétacé Supérieur inférieur (Pliensbachien inférieur à Turonien initial) pour les sédiments associés aux basaltes océaniques ou provenant de blocs dans des brèches ou des mégabrèches du Complexe d'Accrétion de Santa Rosa. Cette étude met en évidence l'âge Jurassique Inférieur d'une séquence de radiolarites rubanées entrecoupée de sills de basaltes alcalins, dont l'âge estimé était précédemment le Crétacé.La présence de blocs plurimétriques de radiolarites d'âge Jurassique Inférieur remaniés dans une mégabrèche polymicte, dont la présence avait été signalée par De Wever et al. (1985), est confirmée. Par conséquent, les basaltes alcalins associés à ces radiolarites pourraient aussi être d'âge Jurassique. Dans la fenêtre tectonique de Carrizal, des blocs de radiolarites d'âge Jurassique Moyen et des radiolarites du Crétacé Inférieur recouvrant des basaltes en coussins sont interprétés comme des fragments d'une croûte océanique d'âge Jurassique Moyen accrétés à une plaque océanique d'âge Crétacé Inférieur, dans un contexte de subduction intra-océanique. Alors que dans la même zone, les radiolarites « noueuses » et les argiles noires associées sont interprétées comme des indicateurs d'un milieu peu profond au Crétacé. D'autres fragments océaniques plus jeunes documentent une approche rapide du lieu de sédimentation vers une fosse de subduction pendant le Crétacé Inférieur supérieur (Albien-Cénomanien), peut-être Crétacé Supérieur (Turonien).Au total, 60 espèces appartenant à 34 genres ont été déterminées à partir de faunes à radiolaires relativement bien préservées, extraites de roches volcanoclastiques et pélagiques à hémipélagiques associées, provenant des terrains de Matambu et Manzanillo et ayant des âges compris entre le Crétacé Supérieur et le Paléogène Inférieur (Turonien moyen-Santonien à Thanétien supérieur-Yprésien). Cette étude montre que les radiolaires peuvent fournir un contrôle stratigraphique significatif dans la Péninsule de Nicoya, où des lithologies similaires, mais d'âges différents sont présentes. Deux échantillons à radiolaires permettent de dater la Formation de Berrugate pour la première fois (Turonien moyen-Santonien et Coniacien-Santonien). Ces âges permettent d'établir une activité volcanique d'arc le long de la marge occidentale de la futur Plaque Caraïbes au moins depuis le Santonien et qui pourrait avoir durée jusqu'au Turonien moyen-Campanien inférieur. De plus, sur la base de ces âges à radiolaires, la Formation de Loma Chumico d'âge Albien, et la Formation de Berrugate d'âge Turonien moyen-Maastrichtien inférieur, peuvent maintenant être différenciées. Deux échantillons de la Formation de Sabana Grande donnent des âges Coniacien-Santonien et Coniacien-Campanien et indiquent qu'il existe une lacune stratigraphique d'environ 10 millions d'années entre cette formation et la Formation de Loma Chumico sous-jacente d'âge Albien.

Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring.

A sensitive and selective ultra-high performance liquid chromatography (UHPLC) tandem mass spectrometry (MS/MS) method was developed for the fast quantification of ten psychotropic drugs and metabolites in human plasma for the needs of our laboratory (amisulpride, asenapine, desmethyl-mirtazapine, iloperidone, mirtazapine, norquetiapine, olanzapine, paliperidone, quetiapine and risperidone). Stable isotope-labeled internal standards were used for all analytes, to compensate for the global method variability, including extraction and ionization variations. Sample preparation was performed by generic protein precipitation with acetonitrile. Chromatographic separation was achieved in less than 3.0min on an Acquity UPLC BEH Shield RP18 column (2.1mm×50mm; 1.7μm), using a gradient elution of 10mM ammonium formate buffer pH 3.0 and acetonitrile at a flow rate of 0.4ml/min. The compounds were quantified on a tandem quadrupole mass spectrometer operating in positive electrospray ionization mode, using multiple reaction monitoring. The method was fully validated according to the latest recommendations of international guidelines. Eight point calibration curves were used to cover a large concentration range 0.5-200ng/ml for asenapine, desmethyl-mirtazapine, iloperidone, mirtazapine, olanzapine, paliperidone and risperidone, and 1-1500ng/ml for amisulpride, norquetiapine and quetiapine. Good quantitative performances were achieved in terms of trueness (93.1-111.2%), repeatability (1.3-8.6%) and intermediate precision (1.8-11.5%). Internal standard-normalized matrix effects ranged between 95 and 105%, with a variability never exceeding 6%. The accuracy profiles (total error) were included in the acceptance limits of ±30% for biological samples. This method is therefore suitable for both therapeutic drug monitoring and pharmacokinetic studies.

Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography-negative chemical ionization-mass spectrometry.

Midazolam is a widely accepted probe for phenotyping cytochrome P4503A. A gas chromatography-mass spectrometry (GC-MS)-negative chemical ionization method is presented which allows measuring very low levels of midazolam (MID), 1-OH midazolam (1OHMID) and 4-OH midazolam (4OHMID), in plasma, after derivatization with the reagent N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide. The standard curves were linear over a working range of 20 pg/ml to 5 ng/ml for the three compounds, with the mean coefficients of correlation of the calibration curves (n = 6) being 0.999 for MID and 1OHMID, and 1.0 for 4OHMID. The mean recoveries measured at 100 pg/ml, 500 pg/ml, and 2 ng/ml, ranged from 76 to 87% for MID, from 76 to 99% for 1OHMID, from 68 to 84% for 4OHMID, and from 82 to 109% for N-ethyloxazepam (internal standard). Intra- (n = 7) and inter-day (n = 8) coefficients of variation determined at three concentrations ranged from 1 to 8% for MID, from 2 to 13% for 1OHMID and from 1 to 14% for 4OHMID. The percent theoretical concentrations (accuracy) were within +/-8% for MID and 1OHMID, within +/-9% for 4OHMID at 500 pg/ml and 2 ng/ml, and within +/-28% for 4OHMID at 100 pg/ml. The limits of quantitation were found to be 10 pg/ml for the three compounds. This method can be used for phenotyping cytochrome P4503A in humans following the administration of a very low oral dose of midazolam (75 microg), without central nervous system side-effects.

Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals.

OBJECTIVE: Plasma adiponectin is strongly associated with various components of metabolic syndrome, type 2 diabetes and cardiovascular outcomes. Concentrations are highly heritable and differ between men and women. We therefore aimed to investigate the genetics of plasma adiponectin in men and women. METHODS: We combined genome-wide association scans of three population-based studies including 4659 persons. For the replication stage in 13795 subjects, we selected the 20 top signals of the combined analysis, as well as the 10 top signals with p-values less than 1.0 x 10(-4) for each the men- and the women-specific analyses. We further selected 73 SNPs that were consistently associated with metabolic syndrome parameters in previous genome-wide association studies to check for their association with plasma adiponectin. RESULTS: The ADIPOQ locus showed genome-wide significant p-values in the combined (p=4.3 x 10(-24)) as well as in both women- and men-specific analyses (p=8.7 x 10(-17) and p=2.5 x 10(-11), respectively). None of the other 39 top signal SNPs showed evidence for association in the replication analysis. None of 73 SNPs from metabolic syndrome loci exhibited association with plasma adiponectin (p>0.01). CONCLUSIONS: We demonstrated the ADIPOQ gene as the only major gene for plasma adiponectin, which explains 6.7% of the phenotypic variance. We further found that neither this gene nor any of the metabolic syndrome loci explained the sex differences observed for plasma adiponectin. Larger studies are needed to identify more moderate genetic determinants of plasma adiponectin.

Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LC.

Meropenem, a carbapenem antibiotic displaying a broad spectrum of antibacterial activity, is administered in Medical Intensive Care Unit to critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF). However, there are limited data available to substantial rational dosing decisions in this condition. In an attempt to refine our knowledge and propose a rationally designed dosage regimen, we have developed a HPLC method to determine meropenem after solid-phase extraction (SPE) of plasma and dialysate fluids obtained from patients under CVVHDF. The assay comprises the simultaneous measurement of meropenem's open-ring metabolite UK-1a, whose fate has never been studied in CVVHDF patients. The clean-up procedure involved a SPE on C18 cartridge. Matrix components were eliminated with phosphate buffer pH 7.4 followed by 15:85 MeOH-phosphate buffer pH 7.4. Meropenem and UK-1a were subsequently desorbed with MeOH. The eluates were evaporated under nitrogen at room temperature (RT) and reconstituted in phosphate buffer pH 7.4. Separation was performed at RT on a Nucleosil 100-5 microm C18 AB cartridge column (125 x 4 mm I.D.) equipped with a guard column (8 x 4 mm I.D.) with UV-DAD detection set at 208 nm. The mobile phase was 1 ml min(-1), using a step-wise gradient elution program: %MeOH/0.005 M tetrabutylammonium chloride pH 7.4; 10/90-50/50 in 27 min. Over the range of 5-100 microg ml(-1), the regression coefficient of the calibration curves (plasma and dialysate) were >0.998. The absolute extraction recoveries of meropenem and UK-1a in plasma and filtrate-dialysate were stable and ranged from 88-93 to 72-77% for meropenem, and from 95-104 to 75-82% for UK-1a. In plasma and filtrate-dialysate, respectively, the mean intra-assay precision was 4.1 and 2.6% for meropenem and 4.2 and 3.7% for UK-1a. The inter-assay variability was 2.8 and 3.6% for meropenem and 2.3 and 2.8% for UK-1a. The accuracy was satisfactory for both meropenem and UK-1a with deviation never exceeding 9.0% of the nominal concentrations. The stability of meropenem, studied in biological samples left at RT and at +4 degrees C, was satisfactory with < 5% degradation after 1.5 h in blood but reached 22% in filtrate-dialysate samples stored at RT for 8 h, precluding accurate measurements of meropenem excreted unchanged in the filtrate-dialysate left at RT during the CVVHDF procedure. The method reported here enables accurate measurements of meropenem in critically ill patients under CVVHDF, making dosage individualisation possible in such patients. The levels of the metabolite UK-1a encountered in this population of patients were higher than those observed in healthy volunteers but was similar to those observed in patients with renal impairment under hemodialysis.

A highly sensitive LC-tandem MS assay for the measurement in plasma and in urine of salbutamol administered by nebulization during mechanical ventilation in healthy volunteers.

The new-generation nebulizers are commonly used for the administration of salbutamol in mechanically ventilated patients. The different modes of administration and new devices have not been compared. We developed a liquid chromatography-tandem mass spectrometry method for the determination of concentrations as low as 0.05 ng/mL of salbutamol, corresponding to the desired plasma concentration after inhalation. Salbutamol quantification was performed by reverse-phase HPLC. Analyte quantification was performed by electrospray ionization-triple quadrupole mass spectrometry using selected reaction monitoring detection ESI in the positive mode. The method was validated over concentrations ranging from 0.05 to 100 ng/mL in plasma and from 0.18 to 135 ng/mL in urine. The method is precise, with mean inter-day coefficient of variation (CV%) within 3.1-8.3% in plasma and 1.3-3.9% in urine, as well as accurate. The proposed method was found to reach the required sensitivity for the evaluation of different nebulizers as well as nebulization modes. The present assay was applied to examine whether salbutamol urine levels, normalized with the creatinine levels, correlated with the plasma concentrations. A suitable, convenient and noninvasive method of monitoring patients receiving salbutamol by mechanical ventilation could be implemented. Copyright © 2011 John Wiley & Sons, Ltd.

Variations of the carcinoembryonic antigen level in the plasma of patients with gynecologie cancers during therapy

In 63 patients with histologically proved gynecologie carcinoma, circulating carcinoembryonic antigen (CEA) was determined by radioimmunoassay before and at two intervals after treatment. Thirty-one patients of 63 had CEA values over 2.5 ng. per milliliter before treatment. In general, the CEA levels were low compared to those found in endodermal carcinoma. The percentage of elevated CEA values was slightly higher in cases of carcinoma of the cervix and corpus uteri than in those of carcinoma of the ovary. All patients with CEA levels greater than 2.5 ng. per milliliter treated by complete surgical resection of tumor showed a drop of CEA levels to below 2.5 ng. per milliliter seven weeks after operation. In contrast, patients with palliative therapy showed no change in CEA values. About half of the patients treated with a complete course of internal and external radiotherapy showed a drop of CEA levels to below 2.5 ng. per milliliter, whereas the other patients showed fluctuating CEA values. No correlation between clinical status and evolution of CEA levels in these patients could be drawn at the present time. The CEA test seems to be of little value for the earl of diagnosis of gynecologie carcinoma but appears to be interesting for the evaluation of therapy and the follow-up of patients with diagnosed cases.

A novel method for quantification of sulfolane (a metabolite of busulfan) in plasma by gas chromatography-tandem mass spectrometry.

The role of busulfan (Bu) metabolites in the adverse events seen during hematopoietic stem cell transplantation and in drug interactions is not explored. Lack of availability of established analytical methods limits our understanding in this area. The present work describes a novel gas chromatography-tandem mass spectrometric assay for the analysis of sulfolane (Su) in plasma of patients receiving high-dose Bu. Su and Bu were extracted from a single 100 μL plasma sample by liquid-liquid extraction. Bu was separately derivatized with 2,3,5,6-tetrafluorothiophenolfluorinated agent. Mass spectrometric detection of the analytes was performed in the selected reaction monitoring mode on a triple quadrupole instrument after electronic impact ionization. Bu and Su were analyzed with separate chromatographic programs, lasting 5 min each. The assay for Su was found to be linear in the concentration range of 20-400 ng/mL. The method has satisfactory sensitivity (lower limit of quantification, 20 ng/mL) and precision (relative standard deviation less than 15 %) for all the concentrations tested with a good trueness (100 ± 5 %). This method was applied to measure Su from pediatric patients with samples collected 4 h after dose 1 (n = 46), before dose 7 (n = 56), and after dose 9 (n = 54) infusions of Bu. Su (mean ± SD) was detectable in plasma of patients 4 h after dose 1, and higher levels were observed after dose 9 (249.9 ± 123.4 ng/mL). This method may be used in clinical studies investigating the role of Su on adverse events and drug interactions associated with Bu therapy.

Determination of trimipramine and its demethylated and hydroxylated metabolites in plasma by gas chromatography-mass spectrometry.

A gas chromatographic-mass spectrometric (GC-MS) method has been developed, for the determination of trimipramine (TRI), desmethyltrimipramine (DTRI), didesmethyltrimipramine (DDTRI), 2-hydroxytrimipramine (2-OH-TRI) and 2-hydroxydesmethyltrimipramine (2-OH-DTRI). The method includes two derivatization steps with trifluoroacetic acid anhydride and N-methyl-N-(tert.-butyldimethyl silyl)trifluoroacetamide and the use of an SE-54 capillary silica column. The limits of quantitation were found to be 2 ng/ml for DTRI and 4 ng/ml for all other substances. Besides, methods have been optimized for the hydrolysis of the glucuronic acid conjugated metabolites. This specific detection method is useful, as polymedication is a usual practice in clinical situations, and its sensitivity allows its use for single-dose pharmacokinetic studies.

Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles.

The antifungal agent fluconazole (FLC) is widely used in clinical practice. Monitoring FLC levels is useful in complicated clinical settings and in experimental infection models. A bioassay using Candida pseudotropicalis, a simple and cost-effective method, is validated only for FLC levels ranging from 5 to 40 mg/liter. An extension of the analytical range is needed to cover most yeast MICs. A new bioassay in RPMI agar containing methylene blue was developed using C. albicans DSY1024, a mutant rendered hypersusceptible to FLC constructed by the deletion of the multidrug efflux transporter genes CDR1, CDR2, CaMDR1, and FLU1. Reproducible standard curves were obtained with FLC concentrations in plasma ranging from 1 to 100 mg/liter (quadratic regression coefficient &gt; 0.997). The absolute sensitivity was 0.026 microg of FLC. The method was internally validated according to current guidelines for analytical method validation. Both accuracy and precision lied in the required +/-15% range. FLC levels measured by bioassay and by high-performance liquid chromatography (HPLC) performed with 62 plasma samples from humans and rats showed a strong correlation (coefficients, 0.979 and 0.995, respectively; percent deviations of bioassay from HPLC values, 0.44% +/- 15.31% and 2.66% +/- 7.54%, respectively). In summary, this newly developed bioassay is sensitive, simple, rapid, and inexpensive. It allows nonspecialized laboratories to determine FLC levels in plasma to within the clinically relevant concentration range and represents a useful tool for experimental treatment models.

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.

Concentrations of liver enzymes in plasma are widely used as indicators of liver disease. We carried out a genome-wide association study in 61,089 individuals, identifying 42 loci associated with concentrations of liver enzymes in plasma, of which 32 are new associations (P = 10(-8) to P = 10(-190)). We used functional genomic approaches including metabonomic profiling and gene expression analyses to identify probable candidate genes at these regions. We identified 69 candidate genes, including genes involved in biliary transport (ATP8B1 and ABCB11), glucose, carbohydrate and lipid metabolism (FADS1, FADS2, GCKR, JMJD1C, HNF1A, MLXIPL, PNPLA3, PPP1R3B, SLC2A2 and TRIB1), glycoprotein biosynthesis and cell surface glycobiology (ABO, ASGR1, FUT2, GPLD1 and ST3GAL4), inflammation and immunity (CD276, CDH6, GCKR, HNF1A, HPR, ITGA1, RORA and STAT4) and glutathione metabolism (GSTT1, GSTT2 and GGT), as well as several genes of uncertain or unknown function (including ABHD12, EFHD1, EFNA1, EPHA2, MICAL3 and ZNF827). Our results provide new insight into genetic mechanisms and pathways influencing markers of liver function.

Antibacterial burst-release from minimal Ag-containing plasma polymer coatings.

Biomaterials releasing silver (Ag) are of interest because of their ability to inhibit pathogenic bacteria including antibiotic-resistant strains. In order to investigate the potential of nanometre-thick Ag polymer (Ag/amino-hydrocarbon) nanocomposite plasma coatings, we studied a comprehensive range of factors such as the plasma deposition process and Ag cation release as well as the antibacterial and cytocompatible properties. The nanocomposite coatings released most bound Ag within the first day of immersion in water yielding an antibacterial burst. The release kinetics correlated with the inhibitory effects on the pathogens Pseudomonas aeruginosa or Staphylococcus aureus and on animal cells that were in contact with these coatings. We identified a unique range of Ag content that provided an effective antibacterial peak release, followed by cytocompatible conditions soon thereafter. The control of the in situ growth conditions for Ag nanoparticles in the polymer matrix offers the possibility to produce customized coatings that initially release sufficient quantities of Ag ions to produce a strong adjacent antibacterial effect, and at the same time exhibit a rapidly decaying Ag content to provide surface cytocompatibility within hours/days. This approach seems to be favourable with respect to implant surfaces and possible Ag-resistance/tolerance built-up.

Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma.

Thioridazine is a commonly prescribed phenothiazine drug administered as a racemate and it is believed that its antipsychotic effect is mainly associated with (R)-thioridazine. A method based on high-performance liquid chromatography has been developed for the determination of the enantiomers of thioridazine and thioridazine 2-sulfone (THD 2-SO2 or sulforidazine) and of the enantiomers of the diastereoisomeric pairs of thioridazine 2-sulfoxide (THD 2-SO or mesoridazine) and thioridazine 5-sulfoxide (THD 5-SO) in the plasma of thioridazine-treated patients. The method involves sequential achiral and chiral HPLC. The limits of quantitation for total (R) + (S) concentrations were found to be 15 ng/ml for thioridazine and 5 ng/ml for its metabolites. The limits for the determination of the (R)/(S) ratios were found to be 60 ng/ml for racemic THD and 10 ng/ml for racemic THD 2-SO, THD 2-SO2, THD 5-SO (FE) and THD 5-SO (SE). The method has been used to determine the concentrations of the enantiomers of thioridazine and of its metabolites in the plasma of a patient treated with 100 mg of racemic thioridazine hydrochloride per os per day for 14 days. The results show a high enantioselectivity in the metabolism of this drug: the (R)/(S) ratios for THD, THD 2-SO (FE), THD 2-SO (SE), THD 2-SO2, THD 5-SO (FE) and THD 5-SO (SE) were found to be 3.90, 1.22, 6.10, 4.10, 0.09 and 28.0, respectively.